9-Aminomethyl-9,10-dihydroanthracene

AMDA
Clinical data
Other names9-Aminomethyl-9,10-dihydroanthracene
Drug classSerotonin 5-HT2A receptor antagonist
ATC code
  • None
Identifiers
  • 1-(9,10-dihydroanthracen-9-yl)methanamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H15N
Molar mass209.292 g·mol−1
3D model (JSmol)
  • c3cccc1c3Cc2ccccc2C1CN
  • InChI=1S/C15H15N/c16-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)15/h1-8,15H,9-10,16H2 checkY
  • Key:GEICAQNIOJFRQN-UHFFFAOYSA-N checkY
 X markNcheckY (what is this?)  (verify)

AMDA, also known as 9-aminomethyl-9,10-dihydroanthracene, is a tricyclic compound and cyclized phenethylamine which acts as a potent and selective antagonist for the 5-HT2A receptor (Ki = 20 nM). It has been used to help study the shape of the 5-HT2A protein, and develop a large family of related derivatives with even higher potency and/or selectivity.

AMDH structure.

Another related compound is AMDH, in which the central cyclohexane ring of AMDA has instead been expanded into a cycloheptane ring. As with AMDA, AMDH shows good affinity for the serotonin 5-HT2A receptor (Ki = 112 nM).